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Objectives: Chronic thromboembolic pulmonary hypertension is due to partial obstruction of the pulmonary ar-
terial bed and may resolve after pulmonary thromboendarterectomy. Persistent pulmonary hypertension, the main
complication after pulmonary thromboendarterectomy, may reflect vessel alterations induced by high flow in un-
obstructed lung territories. The aim of this study was to determine whether correcting high flow led to reversal of
the vasculopathy in piglets.
Methods: The effects of high pulmonary blood flow were investigated 5 weeks after creation of an aortopulmo-
nary shunt (n¼ 10), and reversibility of vessel disease was evaluated at 1 week (n ¼ 10) and 5 weeks after shunt
closure (n ¼ 10), compared to sham-operated animals (n ¼ 10). Hemodynamic variables, pulmonary artery
reactivity, and morphometry were recorded. We also investigated the endothelin, angiopoietin, and nitric oxide
synthase pathways.
Results: High flow increased medial thickness in distal pulmonary arteries (55.6%  1.2% vs 35.9%  0.8%;
P< .0001) owing to an increase of smooth muscle cell proliferation (proliferating cell nuclear antigen labeling).
The endothelium-dependent relaxation was altered (P<.05). This phenomenon was associated to an overexpres-
sion of endothelin-1, endothelin-A, angiopoietin 1, angiopoietin 2, and Tie-2 (P< .05). After 1 week of shunt
closure, all overexpressed genes returned to control values, the proliferation of smooth muscle cells stopped
,and smooth muscle cell apoptosis increased (terminal deoxynucleotidyl transferase–mediated dUTP nick end
labeling), preceding the normalization of the wall thickness hypertrophy and the pulmonary artery vasoreactivity
observed at 5 weeks after shunt closure.
Conclusion: These results demonstrate that endothelin-1 and angiopoietin pathways are involved in vasculop-
athy development and may be important therapeutic targets for preventing persistent pulmonary hypertension
after pulmonary thromboendarterectomy.
Cardiopulmonary Support Mercier et alChronic thromboembolic pulmonary hypertension (CTEPH)
is a life-threatening disease with an overall 5-year survival of
10% in patients whosemean pulmonary artery (PA) pressure
exceeds 50 mm Hg.1 CTEPH is more common than previ-
ously thought and may occur in up to 3.8% of patients
with acute pulmonary embolism.2Organized thromboticma-
terial causing chronic vascular obstruction is the pathogenic
mechanism, and pulmonary thromboendarterectomy (PTE)
provides long-term hemodynamic and functional benefits
and increases life expectancy.3-5 However, PTE is associated
with 5% to 23%mortality, related chiefly to reperfusion pul-
monary edema and persistent pulmonary hypertension (PH)
despite removal of the thrombotic material.3-5
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doi:10.1016/j.jtcvs.2008.07.0691538 The Journal of Thoracic and Cardiovascular STwo vascular territories can be distinguished in the lung
after pulmonary thromboembolism: the obstructed territory
characterized by chronic ischemia and the unobstructed ter-
ritory exposed to chronic high blood flow resulting from
redistribution of the cardiac output.6,7 This unobstructed
territory contributes to the elevated pulmonary vascular re-
sistance,8 inasmuch as chronic high flow causes distal arte-
riopathy with vascular remodeling9,10 similar to that found
in primary PH.11-15
Pulmonary thromboendarterectomy in patients with high
pulmonary vascular resistance is associated with high rates
of mortality and postoperative persistent PH. Preoperative
prostacyclin infusion, which induces PA vasodilatation
and inhibits vascular remodeling, has been found to decrease
post-PTE mortality in patients with preoperative pulmonary
resistance values exceeding 1200 dyne $ s $ cm5.16 These
findings support the hypothesis that the distal arteriopathy
induced by chronic high blood flow in unobstructed territo-
ries may be the cause of persistent PH after PTE.
Knowledge of the pathobiological mechanisms underly-
ing PH has significantly improved over the past decade.
Three pathways seem to play a key role in the development
of PH: endothelin, angiopoietin, and nitric oxide synthase
(NOS).17-19 The endothelial dysfunction seen in PH is asso-
ciated with an imbalance between endothelium-derivedurgery c June 2009
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SAbbreviations and Acronyms
CTEPH ¼ chronic thromboembolic pulmonary
hypertension
eNOS ¼ endothelial nitric oxide synthase
ET ¼ endothelin
iNOS ¼ inducible nitric oxide synthase
NOS ¼ nitric oxide synthase
PA ¼ pulmonary artery
PBS ¼ phosphate-buffered saline
PCNA ¼ proliferating cell nuclear antigen
PH ¼ pulmonary hypertension
PTE ¼ pulmonary thromboendarterectomy
SMC ¼ smooth muscle cell
TUNEL ¼ terminal deoxynucleotidyl transferase–
mediated dUTP nick end labeling
vasoconstrictor/mitogenic factors and vasodilatator/nonmi-
togenic factors. However, few studies to understand
mechanisms underlying CTEPH had been published. An-
giopoietin-1 expression was found to be increased in pa-
tients with CTEPH, as in various other forms of PH.19
We studied the effects of chronic high blood flow to the
lungs in an experimental animal model of aortopulmonary
shunting. We determined whether the effects of high pulmo-
nary blood flow resolved after restoring normal blood flow
to simulate the effects of PTE. We analyzed nitric oxide, en-
dothelin, and angiopoietin pathways to understand patho-
physiologic mechanisms.
MATERIALS AND METHODS
Forty Large White piglets weighing 21  3 kg were used. The study
complied with the ‘‘Principles of Laboratory Animal Care,’’ developed
by the National Society for Medical Research, and the ‘‘Guide for the
Care and Use of Laboratory Animals,’’ written by the Institute of Labora-
tory Animal Resources and published by the National Institutes of Health
(publication No.86-23, revised in 1985).
Experimental Design
The piglets were randomly allocated to four groups (n ¼ 10 in each
group). The studies were done 5 weeks after performing an aortopulmonary
shunt to increase blood flow into PAs (shunt-open group), 1 week (1-week
shunt-closed group) and 5 weeks (5-week shunt-closed group) after closure
of this shunt, and 5 weeks after PA dissection without shunt in the sham
group.
Surgical Procedures
Aortopulmonary shunt. An aortopulmonary shunt was performed
as previously described by Rendas, Lennox, and Reid.20 An 8-mm diameter
polytetrafluoroethylene bypass was implanted between the ascending aorta
and the main PA. Fractionated heparin was given until harvesting of the
lungs or closure of the shunt to avoid postoperative occlusion of the shunt.
Aortopulmonary shunt closure. Themidline sternotomywas re-
opened. After systemic heparinization, the aorta and main PA were partially
clamped on each side of the bypass, which was divided and sutured.The Journal of Thoracic and CHemodynamic Measurements and Lung Harvesting
Pulmonary hemodynamics were measured before the animals were
killed. Aortic blood flow was measured with a flow probe (Transonic Sys-
tems, Inc, Ithaca, NY) placed on the origin of the aorta upstream from the
aortopulmonary shunt. The pulmonary and systemic flow values were mea-
sured downstream from the shunt.
Pressures and blood gases were measured by direct puncture down-
stream from the aortopulmonary shunt. Then, the animal was exsanguinated
and the lungs rapidly removed from the chest. Patency of the shunt was as-
sessed by direct visual inspection. Biopsy specimens weighing 300 to 500
mg from the left upper lobe were snap-frozen in liquid nitrogen and stored
at70C or left to fix in 4% paraformaldehyde solution.
Light Microscopy and Morphometry
Fixed lung sections were processed by standard histologic techniques
and embedded in paraffin. We sought to identify 30 to 40 arteries of less
than 200 mm in diameter in each piglet. Medial thickness (MT) was calcu-
lated as followes:
%MT ¼ (ED ID) 3 100/ED
Where ED ¼ external diameter and ID ¼ internal diameter.
Evaluation of In Situ PA–Smooth Muscle Cell (SMC)
Death and Proliferation and Collagen Accumulation
To assess the PA–SMC proliferation, we evaluated the proliferating cell
nuclear antigen (PCNA). Tissue sections were deparaffinized in xylene, fol-
lowed by treatment with a graded series of alcohol washes, rehydratation in
phosphate-buffered saline (PBS) (pH 7.5), and then incubated with target
retrieval solution (Dako, Trappes, France) into a water bath at 90C for
20 minutes. Endogenous peroxidase activity was blocked with H2O2 in
PBS (3% vol/vol) for 5 minutes. Slides were then washed in PBS and incu-
bated for 30 minutes in a protein-blocking solution consisting of PBS sup-
plemented with 3% bovine serum albumin. The slides were subsequently
incubated for 30 minutes with anti-PCNA mouse monoclonal antibody
(PC-10, 1:200, Dako, Trappes, France). Antibodies were washed off and
the slides were processed with the alkaline phosphatase LSABþ system-
HRP detection kit (DAKO, Carpinteria, Calif). Brown color was generated
by using a diaminobenzidine substrate and nuclei were counterstained with
hematoxylin.
Detection of cells undergoing apoptosis was evaluated by the ApopTag
Red In Situ Apoptosis Detection Kit (Qbiogene, Illkirch, France), as spec-
ified by the manufacturer.
So that collagen accumulation could be assessed, the paraffin-embedded
sections were deparaffinized and stained with Masson trichrome stain.
Assessment of PA reactivity
Pulmonary artery rings were studied as previously described.21 Endothe-
lin-1 (ET-1), sodium nitroprusside, acetylcholine hydrochloride, and indo-
methacin were purchased from Sigma Chemical Company (St Louis, Mo).
Real-Time Quantification by Polymerase Chain
Reaction Assay
Real-timepolymerase chain reactionassaywas conductedaspreviously de-
scribed.12 Except for the report gene 18S, angiopoietins, and Tie-2, all the
primers (ET-1, ETA, ETB, endothelial NOS [eNOS], inducible NOS
[iNOS]) were specific porcine primers previously described by Rondelet and
associates.12 Primers for 18S ribonucleic acid, angiopoietins and Tie-2 had
been used previously in our laboratory for human experimentation and were
designed onPrimerExpress software (AppliedBiosystems,FosterCity,Calif).
Assay of Lung Phosphodiesterase 5 Activity
Phosphodiesterase 5 assays were carried out from frozen lung tissue
according to established procedures.22ardiovascular Surgery c Volume 137, Number 6 1539
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STABLE 1. Changes in hemodynamic variables and blood gas levels induced by opening and by closing an aortopulmonary shunt
Shunt closed
Sham Shunt open One week Five weeks
Weight (kg) 24  4 28  3 46  8 40  6
HR (beats/min) 98  4 89  3 89  9 89  9
Q (L $ min1) 2  0.14 3.3  0.3* 2.14  0.6z 2.2  0.27y
Mean SAP (mm Hg) 55  3 51  4 51  3 57  4
Mean PAP (mm Hg) 10.1  0.5 15.7  1.2* 10.2  2z 10.2  1.2y
PaO2 (mm Hg) 336.65  18 262  19* 282  36 367  20y
PA PO2 (mm Hg) 41.7  2.6 47.2  2.7 38.5  3z 36.5  1.6y
HR, Heart rate; Q, cardiac outflow; SAP, systemic arterial pressure; PAP, pulmonary arterial pressure; PaO2, systemic PO2; PA PO2, pulmonary artery PO2. *P<.05 sham group vs
shunt-open group. yP< .05 shunt-open group vs 5-week shunt-closed group. zP< .05 shunt-open group vs 1-week shunt-closed group.Statistical Analysis
All results are reported as means SEM. The Kolmogorov–Smirnov test
was applied to test for normality of the distribution of each variable. One-
way analysis of covariance was performed using the weight of the piglets
as the covariate, followed by Fisher’s test for between-group comparisons.
All statistical analyses were performed using Statview IV software (Abacus
Concepts, Berkeley, Calif).
RESULTS
Effect of the Aortopulmonary Shunt on
Hemodynamic Variables
None of the piglets died during or after the surgical proce-
dures. The animals in the shunt-closed groups were kept lon-
ger than animals in the other two groups and therefore had
a greater mean weight gain. Aortography performed before
the animals were killed showed that the shunt was patent
in piglets from the shunt-open group and occluded in piglets
from the shunt-closed groups. As summarized in Table 1,
cardiac output and mean PA pressure were elevated in the
shunt-open group. Heart rate and mean arterial pressure
were not significantly changed after 5 weeks of shunting.
Cardiac output and mean PA pressure returned to sham
values 1 and 5 weeks after shunt closure, and no changes
were found in heart rate and mean arterial pressure. As ex-
pected PA PO2 was increased in the shunt-open group com-
pared with the sham group; PA PO2 in the shunt-closed
groups was not significantly different from that in the
sham group. The pulmonary/systemic flow values were sim-
ilar in the shunt-open groups.
Pulmonary Vascular Remodeling
In the sham group, medial wall thickness of PAs less than
200 mm in diameter was 35.9%  0.8%. Five weeks after
shunt creation, distal vascular remodeling was visible as
a significant increase in medial wall thickness when com-
pared with sham values (55.6%  1.2% vs 35.9% 
0.8%; P< .001). Decrease in distal medial thickness fol-
lowed closure of the shunt at 1 week (50%  1.4% vs
55.6%  1.2%; P ¼ .062) and 5 weeks (40.9%  1% vs
55.6%  1.2%; P< .001), respectively. Medial thickness
values returned to near sham values after 5 weeks of closure
of the shunt (Figures 1A and 1B).1540 The Journal of Thoracic and Cardiovascular SuProliferating cell nuclear antigen labeling demonstrated
a proliferation of SMCs in the distal PA wall in shunted
animals. As early as 1 week after shunt closure, the number
of PCNA-positive cells decreased markedly and returned to
sham values (22.4%  15% vs 6%  9%; P < .05).
Conversely, the number of apoptotic cells as detected by
terminal deoxynucleotidyl transferase–mediated dUTP
nick end labeling (TUNEL) in PAwalls in the shunted group
was similar to that in the sham group (6.6%  6% vs 9.2%
 10%; P ¼ not significant), peaked at 1 week after the
shunt closure, and then returned toward sham values at
5 weeks after shunt removal (23.1%  18% vs 9.5% 
9%; P< .05). Collagen accumulation around the PAs was
not different between groups (Figures 2A and 2B).
Pulmonary Vascular Reactivity and Endothelial
Function (Figure 3)
Contraction of PA rings in response to phenylephrine was
not significantly different in the four groups. Incubation of
arteries with increasing doses of ET-1 induced dose-depen-
dent contraction that was similar in the shunt-open, 1-week
shunt-closed, and sham groups. In the 5-week shunt-closed
group, however, maximal contraction induced by ET-1 was
significantly lower than in the sham group (1722 mg vs 2380
mg; P ¼ .019), although median effective concentration
values were not significantly different.
The relaxation response to sodium nitroprusside was not
affected by aortopulmonary shunt creation or occlusion.
Aortopulmonary shunting was followed by a decrease in
maximal relaxation to acetylcholine (51.9%  5.42% vs
66.8%  6.6%; P ¼ .045). Maximal relaxation to acetyl-
choline was not restored 1 week after closure of the shunt
(52.1% 4.62% vs 51.9% 5.42%; P¼ .97) but returned
to normal values at 5 weeks (67.6%  5.4% vs 66.8% 
6.6%; P ¼ .93). Median effective concentration values
were unchanged.
Expression of Genes Involved in the ET-1, NOS, and
Angiopoietin-1 Pathways
Increased lung blood flow induced an increase in ET-1,
ETA, angiopoietin-1, angiopoietin-2, and Tie-2 mRNArgery c June 2009
Mercier et al Cardiopulmonary SupportFIGURE 1. A, Morphometry (3400) of pulmonary arteries of less than 150-mm diameter in the sham group, the shunt-open group, and the shunt-closed
groups. The percentage of medial thickness was the highest in the shunt-open group (P< .05). Medial thickness started to decrease after 1 week of shunt
closure and raised a decrease of 75% after 5 weeks of shunt closure (P<.001). B, Box plot of the percentage of medial thickness of small pulmonary arteries
(<150 mm) in the sham (35.9%  0.8%), shunt-open (55.6%  1.2%), 1-week shunt-closed (48.7%  1%), and 5-week shunt-closed (40.9%  1%)
groups. MT, Medial thickness; ED, external diameter; ID, internal diameter.C
P
Slevels, without changes in steady-state levels of ETB or iNOS
(Figures 4 and 5). For eNOS,mRNA levels were higher in the
shunt-open group than in the sham group, whereas protein
contents in lung tissue were not different (data not shown).
One week after shunt closure, ET-1, ETA, angiopoietin-1,
angiopoietin-2, and Tie-2 mRNA levels returned to normal
values. The normalization of morphometric parameters as
seen 5 weeks after the shunt closure was preceded by a de-
crease of all overexpressed gene mRNA.The Journal of Thoracic andFive weeks after closure of the aortopulmonary shunt, we
observed an increase of ETBmRNA levels and a paradoxical
increase of normalized ET-1 mRNA levels (Figure 4).
Phosphodiesterase 5 Activity
To determine whether the decrease in endothelium-de-
pendent relaxation was related to an increase in phosphodi-
esterase 5 activity induced by high blood flow, we measured
phosphodiesterase 5 activity in lung tissue from piglets in allCardiovascular Surgery c Volume 137, Number 6 1541
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Mercier et al Cardiopulmonary SupportFIGURE 3. Vasoconstriction to endothelin-1 and relaxation to acetylcholine of PA rings from the sham group, the shunt-open group, and the shunt-closed
groups. Aortopulmonary shunting induced a decrease in maximal relaxation to acetylcholine (51.9%  5.42% vs 66.8%  6.6%: P ¼ .045). Five-week
shunt closure was associated with recovery of the maximal relaxation to acetylcholine (67.6%  5.4% vs 66.8%  6.6%; P ¼ .93), whereas its remains
unchanged 1 week after shunt closure. In the 5-weeks shunt-closed group, ET-1-induced maximal contraction was lower than in the sham group (1722
mg vs 2380 mg, P ¼ .019). PA, Pulmonary artery; ET-1, endothelin-1.groups. Phosphodiesterase 5 activity was not affected by
creation or closure of the shunt (data not shown).
DISCUSSION
This study showed that 5 weeks of aortopulmonary shunt-
ing induced pulmonary vasculopathy manifesting as medial
thickness of the distal PAs owing to SMC proliferation, im-
paired endothelium-dependent vasorelaxation, and increase
of ET-1, ETA, angiopoietin-1, angiopoietin-2, and Tie-2 ex-
pression in lung parenchyma. This study also demonstrates
for the first time that after shunt closure, in the early phase
(1 week), we observed a normalization of gene expression
and later (5 weeks) a decrease of distal PA medial thickness,
a normalization of endothelium-dependent vasorelaxation,
and an increase of ETB expression.
After pulmonary embolism, the unobstructed lung terri-
tory is exposed to chronic high blood flow owing to redis-
tribution of the cardiac output.6,7 This overflow inducesThe Journal of Thoracic and Ca progressive increase of PA pressure and shear stress
owing to a distal PA vasculopathy. We also speculate that
the long-term improvement in pulmonary vascular resis-
tance seen after PTE in humans may reflect resolution of
flow-induced arterial disease. Similarly, in patients with se-
vere CTEPH, extensive PA lesions induced by overflow
may result in failure of PTE to lower pulmonary vascular
resistance and, therefore, in increased postoperative morbid-
ity and mortality.6-8 Our model of aortopulmonary shunting
had been previously used as a model of lung disease associ-
ated with congenital heart disorder.12 Because it was not as-
sociated with chronic ischemic lung territories, this model
neglected the potential effect of these territories on the non-
ischemic lung territories. However, this model adequately
reproduces functional vascular changes seen in the unob-
structed territories of patients with CTEPH. Indeed, as in
humans, the aortopulmonary shunting induced a high
pulmonary blood flow and increased PA pressure. To assessC
P
SFIGURE 2. A, Evaluation of in situ PA–SMCs death as assessed by TUNEL (e–h), PA–SMC proliferation by PCNA coloration (a–d), and collagen accu-
mulation byMasson trichrome staining (i–l) in the shunt-open, 1-week shunt-closed, 5-week shunt-closed, and sham groups (3400). Positive cells in TUNEL
and PCNA staining are colored in brown. Collagen is colored in blue byMasson trichrome staining. PAwall thickness in the shunt-open group is related to the
proliferation of SMCs (b) without intravascular collagen accumulation (j). The decrease of PA medial thickness observed 5 weeks after the shunt closure
started at 1 week with a decrease of PCNA-positive cells (c) and increased TUNEL-positive cells (g). PA, Pulmonary artery; SMC, smooth muscle cell;
TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP nick end labelling, PCNA, proliferating cell nuclear antigen. B, Percentage of PCNA- and
TUNEL-positive cells in the wall of distal PAs for all groups of piglets. There is an SMC proliferation in the wall of distal PAs in the shunt-open group
that stopped at the shunt closure. SMCapoptosis increased 1week after the shunt closure and returned to normal value 5weeks after the closure.PA,Pulmonary
artery; SMC, smoothmuscle cell; TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP nick end labelling, PCNA, proliferating cell nuclear antigen.ardiovascular Surgery c Volume 137, Number 6 1543
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SFIGURE 4. Quantification of endothelin-1 (ET-1) and its receptors (ETA and ETB) mRNAs in lung parenchyma by reverse-transcriptase polymerase chain
reaction. High flow in the lungs induced increases in ET-1 and ETAmRNAs but did not change steady-state level of ETB. Shunt closure was followed by early
(1 week) decrease in ET-1 and ETA mRNA levels. ETB mRNA level increased secondarily 5 weeks after the shunt closure.possible therapeutic targets to treat this overflow-induced
vasculopathy, we first investigated the mechanism of
changes in pulmonary vascular wall thickness after shunt
establishment and closure.
In patients with CTEPH, Moser and Braunwald6 had
already reported marked structural changes of chronic PH
in the open PAs. This high flow–induced vasculopathy is
due to high pressure and high shear stress related to the re-
distribution of the cardiac outflow toward the unobstructed
PA bed.7 This distal vasculopathy contributes as well as
the proximal occlusion of PAs to the elevated pulmonary
vascular resistance. Indeed, in our animal model, the over-
flow pulmonary vasculopathy, as induced by 5-week aorto-
pulmonary shunting, was associated with increased medial
thickness of distal PAs related to SMC proliferation as
showed by PCNA labeling. These findings are similar to
the vascular remodeling reported in unobstructed territories
of patients with CTEPH,6 suggesting thus that the overflow,
with the increase of the shear stress that it induces, can be re-1544 The Journal of Thoracic and Cardiovascular Ssponsible for the vascular remodeling. This remodeling is
then associated with the progressive increase of PA resis-
tances. We also found that 1 week after PA flow normaliza-
tion, the SMC proliferation decreased whereas apoptosis, as
assessed by TUNEL, increased markedly. This imbalance
between SMC proliferation and apoptosis was not associated
with alteration of vascular collagen accumulation.
High blood flow in the lungs was associated with an in-
crease in ET-1 and ETA levels in lung tissue. ET-1 is a potent
vasoconstrictor and mitotic peptide for vascular SMCs. ET-1
overexpression has been found in animal studies of flow-
induced PH12-14 and in patients with primary PH.17,18 ET-1
overproduction is probably a response to stimuli such as
shear stress resulting from arterial pressure elevation.23
One week after shunt closure, lung ET-1 and ETA levels
break, whereas PA remodeling still persists. However, 5
weeks after shunt closure, the normalization of PA wall
thickness was associated with restoration of lung ET-1 syn-
thesis. These data suggest that ET-1 may be involved in theFIGURE 5. Quantification of angiopoietin-1, angiopoietin-2 and Tie-2 mRNA levels in the lung parenchyma from sham, shunt-open, and shunt-closed
groups. High flow in the lungs induced an increase in angiopoietin-1, angiopoietin-2, and Tie-2 mRNA levels. Tie-2 mRNA level increased whereas the an-
giopoietin-1/angiopoietin-2 ratio remained the same. Shunt closure was followed by a decrease of expression of these genes.urgery c June 2009
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disease.
Rondelet and associates12 reported that ET-1 inhibition by
the ETA/ETB antagonist bosentan prevented pulmonary
vascular remodeling in a piglet model of high flow–induced
pulmonary vasculopathy. Interestingly, in our model, when
flow was returned to normal by closing the shunt, ETB over-
expression in lung tissue occurred, whereas ETA expression
returned to sham values. ETB is selectively found in the dis-
tal PA bed,24 both on SMCs and on endothelial cells.25 SMC
ETB mediates the same signals as ETA, inducing vasocon-
striction and mitosis. In contrast, endothelial ETB serves
as a clearance receptor for ET-1 and modulates ET-1 expres-
sion via a negative feedback loop and via the release of ves-
sel relaxants such as nitric oxide.23 As the maximal
contraction of PA ring induced by ET-1 was significantly
lower in the 5-week shunt-closed group than in the sham
group, ETB overexpression after shunt closure may reflect
overexpression of the endothelial subtype rather than of
the SMC subtype. ETB and ET-1 expressions follow the
same evolution. This suggests that ETB may play a role in
the control of ET-1 clearance and consequently may contrib-
ute to the regression of the distal arterial abnormalities in-
duced by high flow.
In our study, eNOS RNA expression increased in the
shunt-open group because of chronically increased shear
stress, whereas endothelium-dependent relaxation of isolated
pulmonary rings, which reflects nitric oxide production, was
impaired. Of several studies investigating high-flow PH
and eNOS expression,12,15,26-28 only one15 found increased
eNOS protein levels; this increase was not found in lung
homogenate but instead in fifth-generation isolated PA cells.
In our model, the decrease in endothelium-dependent relax-
ation suggests that flow-induced PH may be related to alter-
ation of the nitric oxide/cyclic guanosine monophosphate
pathway. To investigate this possibility, we measured phos-
phodiesterase 5 activity in lung tissue from piglets with open
aortopulmonary shunt. We found no change in phosphodies-
terase 5 activity. Rondelet and associates29 reported that the
phosphodiesterase 5 inhibitor seldinafil induced a partial
improvement in flow-induced PH in piglets. These results
suggest that alteration of the nitric oxide/cyclic guanosine
monophosphate pathway may result from deterioration in
eNOS activity and/or in nitric oxide stability. After shunt
closure, endothelium-dependent relaxation of isolated PA
rings returned gradually to normal, indicating improved
matching of nitric oxide production to the number of SMCs.
Angiopoietin-1 is a peptide that contributes to lung vessel
development by recruiting and promoting the division of
vascular SMCs.19 Angiopoietin-1 and Tie-2 overexpres-
sions were found in lung parenchyma from patients with
PH.19 Thus, angiopoietin-1 may contribute to the excessive
muscularization of distal PAs that characterizes PH. In our
study, angiopoietin-1 and Tie-2 expressions increased afterThe Journal of Thoracic and Cshunt opening and decreased after shunt closure. However,
angiopoietin-2 expression followed angiopoietin-1 and
Tie-2 expressions. Indeed, angiopoietin-2 blocks the angio-
poietin-1/Tie-2 signal, resulting in a loosening of the tight
vascular structure.30 Altough angiopoietin-2 expression in-
creased in the shunt-open group and then decreased after
the closure of the shunt, the rate angiopoietin-1/angiopoie-
tin-2 remained the same in the four groups whereas Tie-2
was overexpressed in the shunt-open group and returned
to normal in the shunt-closed groups. Thus, our results sup-
port that angiopoietin pathway may contribute to this vascu-
lar remodeling.
CONCLUSION
Flow-induced PA disease is associated with the increase
of ET-1 and Tie-2 expressions in the lung parenchyma.
Shunt closure to replicate the effects of PTE on nonob-
structed lung territories was followed by normalization of
ET-1 and Tie-2 expression and then gradually by resolution
of the arterial abnormalities. These peptides hold promise as
targets for treatments designed to improve PA disease in pa-
tients with CTEPH at risk of persistent PH after PTE.
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